Artecel Sciences, Inc.

4,135.2

2

5/29/2002

Atherotech, Inc.

21,399.9

4

1/31/2005

Avocet Medical, Inc.

36,801.0

3

7/1/2001

BioCryst Pharmaceuticals, Inc.

39,964.9

3

9/30/2007

BioMarin Pharmaceutical, Inc.

53,000.0

2

5/16/2001

BIOQUAL, Inc. (FKA: Diagnon Corporation)

1,351.0

2

5/1/1983

Biosearch, Inc.

1,800.0

2

12/1/1983

Biosym Technologies, Inc.

5,168.0

3

4/1/1992

BioTransplant, Inc.

9,561.0

3

6/30/2001

Cambridge Neuroscience, Inc. (FKA: Synax, Inc.)

35,879.0

9

6/21/1997

Cell Based Delivery, Inc.

11,175.0

2

5/7/2002

Centaur Pharmaceuticals, Inc.

63,451.0

7

11/2/2001

Cephalon, Inc.

40,037.8

8

2/25/1999

Chektec Corporation

846.0

3

4/1/1993

Clarus Medical LLC (Medilase, Inc.)

27,548.9

12

5/1/1997

Clontech Laboratories, Inc.

28,836.0

2

7/1/1998

CoCensys, Inc.

24,071.0

9

1/7/1997

Cognetix, Inc.

19,010.0

2

6/1/2006

CompuCyte Corporation

18,700.0

3

8/1/1999

Conductus, Inc.

45,699.9

6

3/27/2002

Control Delivery Systems, Inc. (AKA: CDS, Inc.)

34,500.0

1

8/22/2000

COR Therapeutics, Inc.

20,652.0

6

1/1/1998

Corixa Corporation

157,581.1

6

6/10/2003

Cortex Pharmaceuticals, Inc.

9,100.0

2

7/1/1989

Creative BioMolecules, Inc.

23,284.0

18

7/1/1995

Cryolife, Inc.

3,057.0

3

6/1/1988

Cryopharm Corporation

30,346.0

10

1/1/1994

Cubist Pharmaceuticals, Inc.

36,283.0

5

9/23/1998

CuraGen Corporation

26,790.0

2

9/1/1999

CytoLogix Corporation

46,850.0

5

5/29/2002

Cytomation, Inc.

14,293.0

2

6/8/2001

Cytyc Corporation (FKA: Generitech Corporation)

35,154.9

4

5/1/1995

Dharmacon Research, Inc.

5,700.0

1

8/23/2002

Digirad Corporation (FKA: Aurora Technologies)

75,320.0

9

4/24/2002

DiscoveRx Corporation, Ltd.

28,406.0

5

2/20/2007

Discovery Laboratories, Inc.

13,211.0

2

6/20/2003

Displaytech, Inc.

70,225.1

5

3/12/2006

Edenspace Systems Corporation

5,250.0

1

4/23/2007

EKOS Corporation

85,900.4

8

6/27/2007

Endocyte, Inc.

60,700.2

4

3/23/2007

Epicyte Pharmaceutical, Inc.

22,200.0

4

4/16/2001

EpiGenesis Pharmaceuticals, Inc.

35,956.2

4

3/7/2007